StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Abbott's (ABT) Novel Diagnostic Test Shows Potential for Rapid Point-of-Care Cardiac Evaluations in New Data Published Online
October 17, 2018 1:10 PM
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care
October 17, 2018 12:44 PM
Abbott (ABT) Reports In-Line Q3 EPS, Offers Q4 Guidance
October 17, 2018 7:47 AM
Barclays Starts Abbott Labs (ABT) at Overweight
October 15, 2018 4:17 PM
Abbott (ABT) Names Robert B. Ford President COO
October 15, 2018 8:31 AM